COMMUNIQUÉS West-GlobeNewswire

Theratechnologies annonce que les National Institutes of Health appuieront une étude avec EGRIFTA(MD) (tésamoréline pour injection) chez des patients séro-négatifs atteints de stéatose hépatique non alcoolique
11/05/2018
MONTRÉAL, 11 mai 2018 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (TSX: TH ) a annoncé aujourd’hui today que le National Institute of Diabetes and Digestive and Kidney Diseases des National Institutes of Health (NIH) aux [...]
Melinta Therapeutics Launches New Antibiotic Stewardship Program to Combat Growing Threat of Antimicrobial Resistance
11/05/2018
Part of Strong Company Presence at 2018 MAD-ID Annual Meeting NEW HAVEN, Conn., May 11, 2018 (GLOBE NEWSWIRE) -- Melinta Therapeutics, Inc. (NASDAQ: MLNT ), a commercial-stage company discovering, developing and [...]
Celsion Corporation Reports First Quarter 2018 Financial Results and Provides Business Update
11/05/2018
Significant Progress in Phase III Liver Cancer and Phase I/II Ovarian Cancer Studies Supported with Solid Fundamentals and a Strong Balance Sheet Company to Hold Conference Call on Friday, May 11, 2018 at 11:00 a.m. EDT [...]
Cocrystal Pharma Reports 2018 First Quarter Financial Results and Provides Corporate Update
11/05/2018
ATLANTA, GA and BOTHELL, WA, May 11, 2018 (GLOBE NEWSWIRE) -- Cocrystal Pharma, Inc. (NASDAQ: COCP), (“Cocrystal” or the “Company”), a clinical stage biotechnology company discovering and developing novel antiviral [...]
Chi-Med to Present at Bank of America Merrill Lynch Annual Health Care Conference
11/05/2018
LONDON, May 11, 2018 (GLOBE NEWSWIRE) -- Hutchison China MediTech Limited (“Chi-Med”) (AIM:HCM) (Nasdaq: HCM ) announced today that Christian Hogg, Chief Executive Officer, will present at the Bank of America Merrill [...]
FIT Biotech Oy: FIT Biotech Oy's Board of Directors has decided on the directed share issue without payment to the Company itself
11/05/2018
FIT Biotech Oy Company release May 11, 2018 at 2.30 pm EET FIT Biotech Oy's Board of Directors has decided on the directed share issue without payment to the Company itself FIT Biotech Oy's Board of Directors has [...]
Cannabis Wheaton Announces Closing of Robinson's Cannabis Acquisition
11/05/2018
VANCOUVER, British Columbia, May 11, 2018 (GLOBE NEWSWIRE) -- Cannabis Wheaton Income Corp. (TSX.V:CBW) (the " Company ") is pleased to announce that it has closed its previously announced acquisition (the " Transaction [...]
eFFECTOR Initiates Randomized Dosing in Phase 2 Checkpoint Combination Trial of eFT508 and Avelumab in Colorectal Cancer
11/05/2018
Dose escalation completed with 200 mg twice daily selected as Phase 2 dose for monotherapy and checkpoint combination trials SAN DIEGO, May 11, 2018 (GLOBE NEWSWIRE) -- eFFECTOR Therapeutics, Inc., a leader in the [...]
Aclaris Therapeutics to Present at the 2018 American Hair Research Summit
11/05/2018
WAYNE, Pa., May 11, 2018 (GLOBE NEWSWIRE) -- Paul Changelian, Ph.D., Vice President, Biology, Aclaris Therapeutics, Inc. (NASDAQ: ACRS ), will speak at the 2018 American Hair Research Summit on “Preclinical to Clinical [...]
Trillium Therapeutics Reports First Quarter 2018 Financial and Operating Results
11/05/2018
Focusing TTI-621 clinical development on T-cell lymphoma TTI-621 received Orphan Drug Designation for the treatment of cutaneous T-cell lymphoma Preclinical data with TTI-622 (SIRPaFc IgG4) presented at AACR; cleared to [...]
Surgery Partners, Inc. to Present at Upcoming Investor Conferences
11/05/2018
NASHVILLE, Tenn., May 11, 2018 (GLOBE NEWSWIRE) -- Surgery Partners, Inc. (NASDAQ: SGRY ) (“Surgery Partners”), a leading healthcare services company, today announced that management will present at the following [...]
Leap Therapeutics Reports First Quarter 2018 Financial Results
11/05/2018
Conference Call with DKN-01 Clinical Investigators Planned for May 18, 2018 CAMBRIDGE, Mass., May 11, 2018 (GLOBE NEWSWIRE) -- Leap Therapeutics, Inc. (NASDAQ: LPTX ), a biotechnology company developing targeted and [...]
Oncolytics Biotech® Reports 2018 First Quarter Results
11/05/2018
CALGARY, Alberta and SAN DIEGO, May 11, 2018 (GLOBE NEWSWIRE) -- Oncolytics Biotech ® Inc. (TSX: ONC ) (OTCQX:ONCYF), currently developing REOLYSIN ® (pelareorep), an intravenously delivered immuno-oncolytic virus [...]
PLx Pharma Inc. Reports First Quarter 2018 Results
11/05/2018
HOUSTON, May 11, 2018 (GLOBE NEWSWIRE) -- PLx Pharma Inc. (NASDAQ: PLXP ) (“PLx” or the “Company”), a late-stage specialty pharmaceutical company focused on commercializing two patent-protected products, Aspertec™ 325 [...]
Achillion Announces Upcoming Scientific Presentations at the 55th ERA-EDTA Congress
11/05/2018
- Oral presentation discussing ACH-4471 and interim biomarker data from the ongoing 14-day Phase 2 study in C3G - - Poster presentation detailing in vitro data showing no significant reduction in serum bactericidal [...]
Shire plc : Rule 2.9 Announcement
11/05/2018
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF THAT JURISDICTION. 11 May 2018 Shire [...]
PUBLICATION IN ACCORDANCE WITH ARTICLE 14 OF THE BELGIAN LAW OF 2 MAY 2007 REGARDING THE PUBLICATION OF MAJOR SHAREHOLDINGS (THE "TRANSPARENCY LAW")
11/05/2018
REGULATED INFORMATION GHENT, Belgium, 11 May 2018 - Ablynx [Euronext Brussels and Nasdaq: ABLX] today announced, in accordance with Article 14 of the Belgian Law of 2 May 2007 regarding the publication of major [...]
Fluidigm Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
11/05/2018
SOUTH SAN FRANCISCO, Calif., May 10, 2018 (GLOBE NEWSWIRE) -- Fluidigm Corporation (NASDAQ: FLDM ) today announced that the Compensation Committee of its Board of Directors, which is comprised entirely of independent [...]
FDA Advisory Committee Votes in Favor of WAYLIVRA for Treatment of Familial Chylomicronemia Syndrome
11/05/2018
Advisory Committee members vote 12-8 to support approval CAMBRIDGE, Mass. and CARLSBAD, Calif., May 10, 2018 (GLOBE NEWSWIRE) -- Akcea Therapeutics, Inc. (NASDAQ: AKCA ), an affiliate of Ionis Pharmaceuticals, Inc., and [...]

Pages